Navigation Links
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Date:10/5/2011

PORTOLA VALLEY, Calif., Oct. 5, 2011 /PRNewswire/ -- In an independent study published in the Journal of Reconstructive Microsurgery, researchers at the University of Texas Health Science Center San Antonio have found that the Spectros T-Stat® oximeter responds earliest to compromised blood flow during reconstructive microsurgery when compared clinically to other available monitors.

This landmark study by Dr. Cornejo and colleagues is important as compromised blood flow to microvascular free flaps causes irreversible damage and/or complete loss of the flap, resulting in longer hospital stays and additional costs to both hospital and patient. While a detailed economic analysis was not an endpoint of this study, earlier detection of tissue compromise results in an improved patient outcome and overall reduced hospital costs.

"These are very strong results supporting the superiority of the T-Stat VLS Oximeter," noted CEO and physician Dr. David Benaron, "This study provides solid evidence that the Spectros broadband light technologies offer the earliest and most sensitive detection of tissue compromise, and suggests that all reconstructive surgery cases can benefit from T-Stat monitoring."

Spectros oximeters are currently the only broadband solid-state tissue oximeters on the market in the U.S. and Europe. T-Stat patented broadband technology provides continuous and real-time absolute measurement of tissue hemoglobin oxygenation using 100s of wavelengths of light, a key advantage over competing oximeter product lines that only use 2 or 4 wavelengths. An expanded array of broadband sensors, including NIRS Continuum® cerebral sensor, is currently in testing, with FDA and EU approval anticipated in 2012.

In reconstructive surgery, T-Stat competes with T.Ox® oximeters marketed by ViOptix and Doppler marketed by Cook Medical. In critical care, the ICU and O.R., T-Stat competes with INVOS® oximeters marketed by Covidien and FORE-SIGHT® oximeters marketed by CAS Medical.

About Spectros

Spectros markets and licenses advanced molecular sensing and imaging devices that shed light on ischemia and cancer. T-Stat was the first medical device FDA-approved as sensitive to ischemia, an insufficient supply of oxygen to tissue, and remains the only commercially-available tissue oximeter that utilizes state-of-the-art broadband spectroscopy. Spectros is a venture-supported private concern and markets its products in the U.S. and internationally.

Spectros also develops molecular diagnostic tools for breast and prostate cancer, including ProstaFluor® contrast agents, currently entering phase I/II clinical trials supported by the National Cancer Institute.  

(Note:  Forward-looking statements are intended as a guide only, and do not constitute an offer for investment. Certain applications described above have not been reviewed by the FDA or European agencies, and are therefore labeled "for investigational use only." T-Stat and Continuum are trademarks of Spectros. INVOS is a trademark of Somanetics and Covidien. FORE-SIGHT is a trademark of CAS Medical).

For further information, visit www.spectros.com.


'/>"/>
SOURCE Spectros
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
2. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
3. Spectros Corp. Enters Into Optical Biotechnology Patent Sale Agreement With Philips Electronics N.V.
4. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
5. ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
6. Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010
7. Spectros White LED Patent Scope Affirmed In U.S. Patent Office Reexamination
8. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010
9. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
10. Spectros Corporation Year-To-Date Oximeter Sales Revenue Up 51% in First Half of 2011
11. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... 2017   PDI , a leader in infection ... an educational session focused on the role of chlorhexidine ... at the 2017 Annual Scientific Meeting of the Association ... at the Phoenix Convention Center ... 16-19, will also feature PDI,s Prevantics® Device Swab ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... September 25, 2017 , ... ... announced today the addition of an affiliate in Minneapolis-St. Paul, MN, Dr. Adam ... accelerated detox, Naltrexone therapy and aftercare planning through his Timewise Medical practice in ...
(Date:9/25/2017)... ... September 25, 2017 , ... Nissar A. Darmani, PhD, ... help cancer patients suffering from chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate ... (COMP). , The five-year grant is from the National Cancer Institute (NCI) arm ...
(Date:9/25/2017)... ... September 25, 2017 , ... Order ... its new website. No need to be concerned about garment selection, expensive ... welldonedesigns.com where all orders are printed and shipped within 5-10 days. And ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... further expand its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and ... POD-based Oral Solid Dosage line. The new PODs will provide tablet coating capability ...
(Date:9/25/2017)... ... , ... Bobbie Horowitz was hardly able to walk without excruciating pain in ... and theater producer, Horowitz would manage to get to rehearsals on time, but wasn’t ... so she had to take a cab everywhere. , It wasn’t until she ...
Breaking Medicine News(10 mins):